产品类别

联系我们

电话:025-68037686

地址:江苏生命科技创新园F6幢1层

订购:nanjing03@biogot.com

服务:biorase01@biogot.com

合作:lvyun@biogot.com

支持:may@biogot.com

ERK 1/2 (phospho-T202) polyclonal antibody（KU）

货号: BS4759

价格：￥ 1350

货期：现货（1-2个工作日）

25ul 50ul 100ul 200ul

抗体定制服务咨询

说明书 MSDS SHIP

详细信息检测数据实验指南文献

No. :BS4759

Product Name :ERK 1/2 (phospho-T202) polyclonal antibody（KU）

Swiss-Prot :P27361/P28482

Host :Rabbit

Reactivity :Human,Mouse,Rat

Applications :WB IF IP

Application_all :WB: 1:500~1:1000 IF: 1:100~1:500

Background :The activation of signal transduction pathways by growth factors, hormones and neurotransmitters is mediated through two closely related MAP kinases, p44 and p42, designated extracellular-signal related kinase 1 (ERK 1) and ERK 2, respectively. ERK proteins are regulated by dual phosphorylation at Tyrosine 204 and 187 and Threonine 177 and 160 residues mapping within a characteristic Thr-Glu-Tyr motif. Phosphorylation at both the Threonine 202 and Tyrosine 204 residues of ERK 1 and Threonine 185 and Tyrosine 187 residues of ERK 2 is required for full enzymatic activation. The structural consequences of dual phosphorylation in ERK 2 include active site closure, alignment of key catalytic residues that interact with ATP, and remodeling of the activation loop. In response to activation, MAP kinases phosphorylate downstream components on serine and threonine. Upstream MAP kinase regulators include MAP kinase kinase (MEK), MEK kinase and Raf-1. The ERK family has three additional members: ERK 3, ERK 5 and ERK 6.

Product :Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Purification&Purity :The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).

Storage&Stability :Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity :p-ERK 1/2 (T202) polyclonal antibody detects endogenous levels of ERK 1 protein only when phosphorylated at Thr202, and ERK 1 protein only when phosphorylated at Thr185.

BiowMW :~ 42,44 kDa

Note :For research use only, not for use in diagnostic procedure.

Alternative Name :Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p44-ERK1; MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 1; MAP kinase 1; MAPK 1; ERT1; Extracellular signal-regulated kinase 2; ERK-2; MAP kinase isoform p42; p42-MAPK; Mitogen-activated protein kinase 2; MAP kinase 2; MAPK 2; MAPK1; ERK2; PRKM1; PRKM2

Immunogen :Synthetic phosphopeptide derived from human ERK1/2 around the phosphorylation site of Threonine 202.

Conjugate :Unconjugated

Modification :Phosphorylated

Western blot (WB) analysis of p-ERK 1/2 (T202) polyclonal antibody at 1:500 dilution Lane1:Hela cell lysate treated with PMA(100nM,15mins) Lane2:H9C2 cell lysate treated with PMA(100nM,15mins) Lane3:PC12 cell lysate treated with PMA(100nM,15mins)

Western blot (WB) analysis of p-ERK1/2 (T202) pAb at 1:500 dilution Lane1:L02 starved for 16 hours whole cell lysate(40ug) Lane2:L02 starved for 16 hours then treated with LPS(1000ng/ml) for 5 minutes whole cell lysate Lane3:L02 starved for 16 hours then treated with LPS(1000ng/ml) for 15 minutes whole cell lysate Lane4:L02 starved for 16 hours then treated with LPS(1000ng/ml) for 30 minutes whole cell lysate

Immunofluorescence analysis of Hela cells using ERK 1/2 (phospho-T202) pAb at dilution of 1:200 (40x lens).

Neuroprotective effect of Ginsenoside Re against neurotoxin‑induced Parkinson's disease models via induction of Nrf2

JournalMolecular Medicine Reports

ApplicationWB

IF2.952

SpeciesHuman

PMID35543148
TREM1/DAP12 based novel multiple chain CAR-T cells targeting DLL3 show robust anti-tumour efficacy for small cell lung cancer

JournalIMMUNOLOGY

ApplicationWB

IF6.4

SpeciesHuman

PMID38469682
Tröger’s Base as a Potential Bridge to Type-I Photosensitizers: Mechanism and Antitumor Applications

JournalJOURNAL OF MEDICINAL CHEMISTRY

ApplicationWB

IF6.8

SpeciesHuman

PMID39772640
Tumor-expressing PD-L1 regulates NT5E expression through MAPK/ERK pathway in triple-negative breast cancer

JournalONCOLOGY RESEARCH

ApplicationWB

IF4.1

SpeciesHuman

PMID40612859